Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H T Schambye

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Effect of different buffers on the biocompatibility of CAPD solutionsH T Schambye
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluentsH T Schambye, F B Pedersen, P Wang
Ugeskrift for Laeger|November 1, 1993
[Non-peptide antagonists to angiotensin II receptors. A review]H T Schambye, S A Hjorth, T W Schwartz
Molecular Pharmacology|March 1, 1995
Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptorH T Schambye, S A Hjorth, J Weinstock, et al.
The Journal of Biological Chemistry|December 9, 1994
Identification of peptide binding residues in the extracellular domains of the AT1 receptorS A Hjorth, H T Schambye, W J Greenlee, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1993
The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratiosH T Schambye, F B Pedersen, H K Christensen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 1994
Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptorsH T Schambye, S A Hjorth, D J Bergsma, et al.
The Journal of Biological Chemistry|January 27, 1995
Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptorS Perlman, H T Schambye, R A Rivero, et al.
Molecular Human Reproduction|March 25, 2006
Transcriptome analysis of FSH and FSH variant stimulation in granulosa cells from IVM patients reveals novel regulated genesS Perlman, T Bouquin, B van den Hazel, et al.
British Journal of Pharmacology|October 1, 1994
Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonistsH T Schambye, B von Wijk, S A Hjorth, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Effect of different buffers on the biocompatibility of CAPD solutionsH T Schambye
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluentsH T Schambye, F B Pedersen, P Wang
Ugeskrift for Laeger|November 1, 1993
[Non-peptide antagonists to angiotensin II receptors. A review]H T Schambye, S A Hjorth, T W Schwartz
Molecular Pharmacology|March 1, 1995
Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptorH T Schambye, S A Hjorth, J Weinstock, et al.
The Journal of Biological Chemistry|December 9, 1994
Identification of peptide binding residues in the extracellular domains of the AT1 receptorS A Hjorth, H T Schambye, W J Greenlee, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1993
The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratiosH T Schambye, F B Pedersen, H K Christensen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 1994
Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptorsH T Schambye, S A Hjorth, D J Bergsma, et al.
The Journal of Biological Chemistry|January 27, 1995
Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptorS Perlman, H T Schambye, R A Rivero, et al.
Molecular Human Reproduction|March 25, 2006
Transcriptome analysis of FSH and FSH variant stimulation in granulosa cells from IVM patients reveals novel regulated genesS Perlman, T Bouquin, B van den Hazel, et al.
British Journal of Pharmacology|October 1, 1994
Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonistsH T Schambye, B von Wijk, S A Hjorth, et al.
Pageof 2